Patents by Inventor David Feifel

David Feifel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PSYCHEDELIC DRUG TREATMENT OF NEUROPSYCHIATRIC DISORDERS AND CEREBRAL PALSY
    Publication number: 20250195537
    Abstract: Provided is a method of treating a mental disorder in a patient. Also provided is a method of enhancing a therapeutic effect of a psychedelic drug in a patient with a mental disorder. Additionally provided is a method of reducing an adverse effect of a psychedelic drug in a patient. Further provided is the use of an anxiolytic to enhance a therapeutic effect of a psychedelic drug in a patient with a mental disorder. Also provided is a method of treating cerebral palsy in a patient.
    Type: Application
    Filed: June 22, 2022
    Publication date: June 19, 2025
    Inventor: David Feifel
  • METHODS FOR IMPROVING THE COGNITIVE FUNCTIONS OF A SUBJECT
    Publication number: 20200000873
    Abstract: The disclosure provides for methods to improve the executive function of a subject by administering an effective amount of an oxytocin peptide, analog or mimetic.
    Type: Application
    Filed: January 31, 2018
    Publication date: January 2, 2020
    Inventors: David Feifel, Jared Young
  • Oxytocin treatment to modify blood glucose and treat metabolic disease
    Patent number: 10314885
    Abstract: The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analog thereof having a beneficial effect.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: June 11, 2019
    Assignee: The Regents of the University of California
    Inventor: David Feifel
  • OXYTOCIN TREATMENT TO IMPROVE MEMORY AND MODIFY BLOOD GLUCOSE
    Publication number: 20170224763
    Abstract: The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analogue thereof having a beneficial effect.
    Type: Application
    Filed: February 28, 2017
    Publication date: August 10, 2017
    Inventor: David Feifel
  • Intranasal oxytocin treatment to improve schizophrenia
    Patent number: 9585935
    Abstract: The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analog thereof having a beneficial effect.
    Type: Grant
    Filed: July 30, 2011
    Date of Patent: March 7, 2017
    Assignee: The Regents of the University of California
    Inventor: David Feifel
  • OXYTOCIN TREATMENT TO IMPROVE MEMORY AND MODIFY BLOOD GLUCOSE
    Publication number: 20130231279
    Abstract: The disclosure provides a method for enhancing memory of a subject, lowering blood glucose levels in a subject, and treating schizophrenia, the methods comprise intranasally administering to the subject an amount of a oxytocin peptide or analogue thereof having a beneficial effect.
    Type: Application
    Filed: July 30, 2011
    Publication date: September 5, 2013
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventor: David Feifel
  • Method of inhibiting neural transmission mediated by serotonin-2a and enhancing sensorimotor gating
    Publication number: 20060179492
    Abstract: Disclosed are methods for treating neuropsychiatric disorders and disorders associated with sensorimotor gating deficits and/or prepulse inhibition disorders and improving sensorimotor gating in normal subjects. Also provided are animal models useful for identifying agents that modulate sensorimotor gating activity for preclinical testing of psychotropic drugs.
    Type: Application
    Filed: December 8, 2003
    Publication date: August 10, 2006
    Applicant: The Regents of the University of California
    Inventor: David Feifel